Xbiotech inc.

Major-Pharmaceuticals

XBIT


Building 4
Austin , TX 78744

Executive/
Director

Price

  • Last Close
  • $ 6.86
    $ +0.16 2.39 %
    Aug 29, 2024
  • 52-Week High/Low
  • $9.84 - $3.56
  • YTD
  • 71.5%

  • Trading Volume
  • 1,910
  • Market Cap Full
  • $ 208.8M
  • Shares Outstanding
  • 30.4M
    Nov 9, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - -13.1% 62.9% 35.8% 116.9% -5% 9.7% -22.4% -1.7% 103.3%
Q2 -22.2% 121.4% -71.5% -12.7% -32.8% 4% -3.5% -34.8% 72.2% 7.9%
Q3 -17.4% -35.7% -7% -28.7% 39.3% 8% -21.2% -35.7% -30.6% -
Q4 -27.2% -24.8% -10.3% 56.8% 83% -18% -14.7% -3% 3.9% -
J F M A M J J A S O N D
2024 14.8% 36.4% 29.9% 4.2% - - - - - - - -
2023 23.9% -22.8% 2.7% -0.3% 48.1% 16.6% -15.3% -2.2% -16.3% 1.5% -6.2% 2%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%-7%-61%29%273%-17%-29%-68%14%72%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.29 0.32 0.32 - 0.16 - -0.09 -0.18 -0.13
Q2 0.22 0.42 - - 0.16 -0.24 -0.17 -0.38 -0.29
Q3 0.33 0.38 - 0.14 - -0.09 -0.11 -0.42 -0.24
Q4 0.37 0.51 - - 14.59 -0.03 -0.21 -0.10 -
A 1.2 1.6 0.3 -0.6 14.4 -0.4 -0.6 -1.1 -0.66

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

Dividend +

Dividend +

2021
Q1 2.5
Q2 -
Q3 -
Q4 -
A 2.5
2018 2019 2020 2021 2022 2023
Mar - 36 28.9 29.5 30.4 30.4
Jun 35.5 36.1 28.9 30 30.4 30.4
Sep 35.8 41 29 30.4 30.4 30.4
Dec 35.8 41.1 29.3 30.4 30.4 30.4

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 0.2 0.6 1.6 - -
Total Asset Turnover - 0.1 0.1 - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 34 3.1 2.6 - -
Equity multiplier 0.1 0.1 0.1 - 0.7